{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:42:50Z","timestamp":1789587770551,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008106","name":"Reumatikerdistriktet i G\u00f6teborg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1315-z","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T11:56:42Z","timestamp":1495108602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-0144","authenticated-orcid":false,"given":"Karin","family":"Bengtsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Forsblad-d\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Dehlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Exarchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart T. H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"1315_CR1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","volume":"20","author":"J Sieper","year":"2006","unstructured":"Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol. 2006;20:401\u201317.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"1","key":"1315_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76(1):17\u201328. doi: 10.1136\/annrheumdis-2016-209775 . 6.","journal-title":"Ann Rheum Dis"},{"key":"1315_CR3","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","volume":"63","author":"SM Szabo","year":"2011","unstructured":"Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum. 2011;63:3294\u2013304.","journal-title":"Arthritis Rheum."},{"key":"1315_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00296-013-2912-z","volume":"34","author":"JJ Keller","year":"2014","unstructured":"Keller JJ, Hsu JL, Lin SM, Chou CC, Wang LH, Wang J, et al. Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study. Rheumatol Int. 2014;34:255\u201363.","journal-title":"Rheumatol Int."},{"key":"1315_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/03009742.2013.822097","volume":"43","author":"CH Chou","year":"2014","unstructured":"Chou CH, Lin MC, Peng CL, Wu YC, Sung FC, Kao CH, et al. A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis. Scand J Rheumatol. 2014;43:132\u20136.","journal-title":"Scand J Rheumatol."},{"key":"1315_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2012.02.008","volume":"42","author":"S Brophy","year":"2012","unstructured":"Brophy S, Cooksey R, Atkinson M, Zhou SM, Husain MJ, Macey S, et al. No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data. Semin Arthritis Rheum. 2012;42:140\u20135.","journal-title":"Semin Arthritis Rheum."},{"key":"1315_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","volume":"75","author":"I Essers","year":"2016","unstructured":"Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, et al. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis. 2016;75:203\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163:409\u201316.","journal-title":"Ann Intern Med."},{"issue":"2","key":"1315_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","volume":"76","author":"JK Eriksson","year":"2017","unstructured":"Eriksson JK, Jacobsson L, Bengtsson K, Askling J. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis. 2017;76(2):364\u201370. doi: 10.1136\/annrheumdis-2016-209315 .","journal-title":"Ann Rheum Dis"},{"key":"1315_CR10","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson Jr DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167\u201372.","journal-title":"J Rheumatol."},{"key":"1315_CR11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013;2, e000062.","journal-title":"J Am Heart Assoc."},{"key":"1315_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018125","volume":"6","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Lindhardsen J, Charlot MG, Jorgensen CH, Olesen JB, et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One. 2011;6, e18125.","journal-title":"PLoS One."},{"key":"1315_CR13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","volume":"55","author":"AL Neimann","year":"2006","unstructured":"Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829\u201335.","journal-title":"J Am Acad Dermatol."},{"key":"1315_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","volume":"270","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011;270:147\u201357.","journal-title":"J Intern Med."},{"key":"1315_CR15","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","volume":"129","author":"JM Gelfand","year":"2009","unstructured":"Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129:2411\u20138.","journal-title":"J Invest Dermatol."},{"key":"1315_CR16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735\u201341.","journal-title":"JAMA."},{"key":"1315_CR17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015;74:326\u201332.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/RHU.0000000000000306","volume":"21","author":"L Li","year":"2015","unstructured":"Li L, Hagberg KW, Peng M, Shah K, Paris M, Jick S. Rates of cardiovascular disease and major adverse cardiovascular events in patients with psoriatic arthritis compared to patients without psoriatic arthritis. J Clin Rheumatol. 2015;21:405\u201310.","journal-title":"J Clin Rheumatol."},{"key":"1315_CR19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2133.2011.10774.x","volume":"166","author":"WQ Li","year":"2012","unstructured":"Li WQ, Han JL, Manson JE, Rimm EB, Rexrode KM, Curhan GC, et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol. 2012;166:811\u20138.","journal-title":"Br J Dermatol"},{"key":"1315_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","volume":"72","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72:211\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","volume":"88","author":"C Gonzalez-Juanatey","year":"2009","unstructured":"Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, et al. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore). 2009;88:358\u201365.","journal-title":"Medicine (Baltimore)"},{"key":"1315_CR22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","volume":"59","author":"LS Tam","year":"2008","unstructured":"Tam LS, Shang Q, Li EK, Tomlinson B, Chu TT, Li M, et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum. 2008;59:1322\u201331.","journal-title":"Arthritis Rheum."},{"key":"1315_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","volume":"36","author":"O Kimhi","year":"2007","unstructured":"Kimhi O, Caspi D, Bornstein NM, Maharshak N, Gur A, Arbel Y, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007;36:203\u20139.","journal-title":"Semin Arthritis Rheum."},{"key":"1315_CR24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57:1074\u201380.","journal-title":"Arthritis Rheum."},{"key":"1315_CR25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","volume":"63","author":"A Bremander","year":"2011","unstructured":"Bremander A, Petersson IF, Bergman S, Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2011;63:550\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1315_CR26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ard.2009.116178","volume":"69","author":"JH Kang","year":"2010","unstructured":"Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis. 2010;69:1165\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","volume":"75","author":"AM Gulati","year":"2016","unstructured":"Gulati AM, Semb AG, Rollefstad S, Romundstad PR, Kavanaugh A, Gulati S, et al. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trondelag Health Study. Ann Rheum Dis. 2016;75:819\u201324.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR28","first-page":"877","volume":"35","author":"L Eder","year":"2008","unstructured":"Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol. 2008;35:877\u201382.","journal-title":"J Rheumatol."},{"key":"1315_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/03009742.2015.1010572","volume":"44","author":"U Lindstrom","year":"2015","unstructured":"Lindstrom U, Exarchou S, Sigurdardottir V, Sundstrom B, Askling J, Eriksson JK, et al. Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register. Scand J Rheumatol. 2015;44:369\u201376.","journal-title":"Scand J Rheumatol."},{"key":"1315_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098024","volume":"9","author":"S Lofvendahl","year":"2014","unstructured":"Lofvendahl S, Theander E, Svensson A, Carlsson KS, Englund M, Petersson IF. Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study. PLoS One. 2014;9, e98024.","journal-title":"PLoS One."},{"key":"1315_CR31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health."},{"key":"1315_CR32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/2012.jama.11741","volume":"308","author":"ME Holmqvist","year":"2012","unstructured":"Holmqvist ME, Neovius M, Eriksson J, Mantel A, Wallberg-Jonsson S, Jacobsson LT, et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA. 2012;308:1350\u20136.","journal-title":"JAMA."},{"key":"1315_CR33","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/acr.22039","volume":"65","author":"SC Kim","year":"2013","unstructured":"Kim SC, Schneeweiss S, Liu J, Solomon DH. Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65:1600\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1315_CR34","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/annrheumdis-2012-201669","volume":"72","author":"HK Choi","year":"2013","unstructured":"Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis. 2013;72:1182\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","volume":"375","author":"MJ Grainge","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657\u201363.","journal-title":"Lancet."},{"key":"1315_CR36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","volume":"16","author":"JJ Lee","year":"2014","unstructured":"Lee JJ, Pope JE. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases. Arthritis Res Ther. 2014;16:435.","journal-title":"Arthritis Res Ther."},{"key":"1315_CR37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(03)00266-7","volume":"2","author":"VL Feigin","year":"2003","unstructured":"Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43\u201353.","journal-title":"Lancet Neurol."},{"key":"1315_CR38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00415-006-0201-4","volume":"253","author":"JM Ferro","year":"2006","unstructured":"Ferro JM. Update on intracerebral haemorrhage. J Neurol. 2006;253:985\u201399.","journal-title":"J Neurol."},{"key":"1315_CR39","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/STROKEAHA.108.540112","volume":"40","author":"KK Andersen","year":"2009","unstructured":"Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009;40:2068\u201372.","journal-title":"Stroke."},{"key":"1315_CR40","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1161\/01.STR.0000141701.36371.d1","volume":"35","author":"PM Rothwell","year":"2004","unstructured":"Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, et al. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004;35:2300\u20135.","journal-title":"Stroke."},{"key":"1315_CR41","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/STROKEAHA.107.504498","volume":"39","author":"P Welsh","year":"2008","unstructured":"Welsh P, Lowe GDO, Chalmers J, Campbell DJ, Rumley A, Neal BC, et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke. 2008;39:2226\u201330.","journal-title":"Stroke."},{"key":"1315_CR42","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","volume":"32","author":"NS Rost","year":"2001","unstructured":"Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575\u20139.","journal-title":"Stroke."},{"key":"1315_CR43","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000046771.12875.6C","volume":"107","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:I9\u201316.","journal-title":"Circulation."},{"key":"1315_CR44","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1160\/TH14-06-0563","volume":"113","author":"N Riva","year":"2015","unstructured":"Riva N, Donadini MP, Ageno W. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation. Thromb Haemost. 2015;113:1176\u201383.","journal-title":"Thromb Haemost."},{"key":"1315_CR45","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.109.921460","volume":"121","author":"AG Holst","year":"2010","unstructured":"Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010;121:1896\u2013903.","journal-title":"Circulation."},{"key":"1315_CR46","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/archinte.159.16.1886","volume":"159","author":"PO Hansson","year":"1999","unstructured":"Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: \u201cthe study of men born in 1913\u201d. Arch Intern Med. 1999;159:1886\u201390.","journal-title":"Arch Intern Med."},{"key":"1315_CR47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","volume":"117","author":"W Ageno","year":"2008","unstructured":"Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93\u2013102.","journal-title":"Circulation."},{"key":"1315_CR48","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","volume":"162","author":"AW Tsai","year":"2002","unstructured":"Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182\u20139.","journal-title":"Arch Intern Med."},{"key":"1315_CR49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/aje\/kwi309","volume":"162","author":"RJ Glynn","year":"2005","unstructured":"Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162:975\u201382.","journal-title":"Am J Epidemiol."},{"key":"1315_CR50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.116.024507","volume":"135","author":"BK Mahmoodi","year":"2017","unstructured":"Mahmoodi BK, Cushman M, Anne Naess I, Allison MA, Jan Bos W, Braekkan SK, et al. Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation. 2017;135:7\u201316.","journal-title":"Circulation."},{"key":"1315_CR51","doi-asserted-by":"crossref","first-page":"II2","DOI":"10.1161\/01.CIR.0000122867.89751.59","volume":"109","author":"JT Willerson","year":"2004","unstructured":"Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2\u201310.","journal-title":"Circulation."},{"key":"1315_CR52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/annrheumdis-2012-201387","volume":"72","author":"M Holmqvist","year":"2013","unstructured":"Holmqvist M, Gransmark E, Mantel A, Alfredsson L, Jacobsson LT, Wallberg-Jonsson S, et al. Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis. Ann Rheum Dis. 2013;72:541\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1315_CR53","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar4584","volume":"16","author":"L Ljung","year":"2014","unstructured":"Ljung L, Askling J, Rantapaa-Dahlqvist S, Jacobsson L. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study. Arthritis Res Ther. 2014;16:R127.","journal-title":"Arthritis Res Ther."},{"key":"1315_CR54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/art.30654","volume":"64","author":"L Ljung","year":"2012","unstructured":"Ljung L, Simard JF, Jacobsson L, Rantapaa-Dahlqvist S, Askling J. Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis. Arthritis Rheum. 2012;64:42\u201352.","journal-title":"Arthritis Rheum."},{"key":"1315_CR55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000345953","volume":"40","author":"M Koster","year":"2013","unstructured":"Koster M, Asplund K, Johansson A, Stegmayr B. Refinement of Swedish administrative registers to monitor stroke events on the national level. Neuroepidemiology. 2013;40:240\u20136.","journal-title":"Neuroepidemiology."},{"key":"1315_CR56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrcardio.2013.93","volume":"10","author":"V Vaccarino","year":"2013","unstructured":"Vaccarino V, Badimon L, Corti R, De Wit C, Dorobantu M, Manfrini O, et al. Presentation, management, and outcomes of ischaemic heart disease in women. Nat Rev Cardiol. 2013;10:508\u201318.","journal-title":"Nat Rev Cardiol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1315-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T02:09:37Z","timestamp":1719194977000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1315-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1315-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]},"article-number":"102"}}